Eris Brings Breakthrough Diabetes Therapy Within Reach with launch of weekly shot of Semaglutide starting at ₹220 per shot
India – 20th March, 2026 :Eris Lifesciences Limited (“Eris Lifesciences” or the “Company”) (BSE: 540596; NSE: ERIS), a leading Indian branded formulations company, today announced a breakthrough step in expanding…
